Sign in
Taking people in South KoreaNo phase

Studying Respiratory Viruses in Hospital Patients With Sudden Heart Failure

Observes respiratory virus infections in adults admitted with sudden heart failure.

Key facts

Who runs it
Minjae Yoon
Where
Seongnam-si and Seoul, South KoreaSee the 3 sites
Trial code
Registry title
Respiratory Virus Infections in Acute Heart Failure
Status
Recruiting
People taking part
360 people, planned
Started
7 Apr 2025
Expected to end
31 Dec 2028
Type of study
Observational
Record updated
11 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in hospital with acute heart failure who may have a respiratory virus infection and have a nose and throat swab virus test within 72 hours of admission.

Age
19 years or older
Sex
All sexes can join
Disease stage
Admitted to the cardiology department with acute heart failure; NT-proBNP >300 pg/mL
Biomarker or test result
NT-proBNP >300 pg/mL; a nasopharyngeal swab for respiratory virus PCR test within 72 hours of admission

Main reasons for not taking part

  • A clear other cause of acute heart failure, such as ACS, bradycardia needing a pacemaker, uncontrolled tachycardia, uncontrolled severe hypertension, haemoglobin <7g/dL or missed medication
  • Pulmonary oedema mainly caused by worsening CKD
  • A clear other source of infection that explains the fever

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult aged 19 years or older admitted to the cardiology department with acute heart failure
  • NT-proBNP >300 pg/mL
  • Clinician judgement of possible respiratory viral infection (fever >38 degrees or cough, respiratory symptoms such as sputum or consolidation on x-ray or CRP >5 mg/dL)
  • Patients who have a nasopharyngeal swab for respiratory virus PCR test performed within 72 hours of admission for any of the 3 reasons

Who cannot take part

  • If there is a clear other source of infection that can explain the fever
  • Patients with a clear other cause of acute heart failure (ex. ACS, bradycardia requiring a pacemaker, uncontrolled tachycardia, uncontrolled severe hypertension (SBP >180mmHg or DBP >110mmHg), haemoglobin <7g/dL or AHF precipitated by medication non-adherence)
  • If the cause of pulmonary oedema is prominently attributed to exacerbation of CKD

Where in South Korea

  • Seoul National University Bundang HospitalSeongnam-si, South KoreaContact: Minjae Yoon, MDTaking people
  • Samsung Medical CenterSeoul, South KoreaContact: Darae KimTaking people
  • Seoul St. Mary's HospitalSeoul, South KoreaContact: Jong-Chan YounTaking people

About the trial

What the trial wants to find out

Patients admitted to the cardiology department with acute heart failure who have a nasopharyngeal respiratory virus PCR test performed within 72 hours of admission will be enrolled in the study cohort.

Read full original descriptionShow less

The detection rate of respiratory viruses including influenza virus, RSV, and coronavirus will be analysed. The investigators will also look for seasonal changes in the frequency of respiratory viruses and differences in the clinical presentation of heart failure based on respiratory virus infection.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Respiratory Virus Infections in Hospitalized Patients With Acute Heart Failure Syndrome: A Prospective Multi-center Observational Study
Plain-language title
Studying Respiratory Viruses in Hospital Patients With Sudden Heart FailureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
11 March 2026